Compare, Analyse Sun Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   ACTAVIS
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
ACTAVIS
Dec-18
SUN PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs48414,367-   
Low Rs3159,638-   
Sales per share (Unadj.) Rs136.93,524.3-  
Earnings per share (Unadj.) Rs17.4-1,135.2-  
Cash flow per share (Unadj.) Rs26.0371.4-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs188.714,536.1-  
Shares outstanding (eoy) m2,399.34332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.93.4 85.7%   
Avg P/E ratio x22.9-10.6 -216.6%  
P/CF ratio (eoy) x15.432.3 47.6%  
Price / Book Value ratio x2.10.8 256.6%  
Dividend payout %22.90-   
Avg Mkt Cap Rs m958,8943,992,036 24.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m63,6240-   
Avg. sales/employee Rs ThNM69,360.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,340.9-  
INCOME DATA
Net Sales Rs m328,3751,172,185 28.0%  
Other income Rs m6,51622,416 29.1%   
Total revenues Rs m334,8911,194,601 28.0%   
Gross profit Rs m67,13530,717 218.6%  
Depreciation Rs m20,528501,084 4.1%   
Interest Rs m3,02767,642 4.5%   
Profit before tax Rs m50,096-515,592 -9.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0131,497 0.0%   
Tax Rs m8,228-6,534 -125.9%   
Profit after tax Rs m41,868-377,561 -11.1%  
Gross profit margin %20.42.6 780.2%  
Effective tax rate %16.41.3 1,296.0%   
Net profit margin %12.8-32.2 -39.6%  
BALANCE SHEET DATA
Current assets Rs m316,542480,769 65.8%   
Current liabilities Rs m157,064425,304 36.9%   
Net working cap to sales %48.64.7 1,026.4%  
Current ratio x2.01.1 178.3%  
Inventory Days Days15820 809.0%  
Debtors Days Days10566 157.9%  
Net fixed assets Rs m334,230132,685 251.9%   
Share capital Rs m2,3990-   
"Free" reserves Rs m450,2450-   
Net worth Rs m452,6454,834,715 9.4%   
Long term debt Rs m20,2891,702,478 1.2%   
Total assets Rs m650,7727,557,759 8.6%  
Interest coverage x17.5-6.6 -265.0%   
Debt to equity ratio x00.4 12.7%  
Sales to assets ratio x0.50.2 325.3%   
Return on assets %6.9-4.1 -168.2%  
Return on equity %9.2-7.8 -118.4%  
Return on capital %11.2-4.8 -232.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m46,2550-   
CASH FLOW
From Operations Rs m65,548418,777 15.7%  
From Investments Rs m-25,888230,064 -11.3%  
From Financial Activity Rs m-57,151-718,747 8.0%  
Net Cashflow Rs m-13,857-69,557 19.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.25 Rs / USD

Compare SUN PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: ADESHWAR MEDITEX  SMS PHARMA  NGL FINE CHM  IOL CHEMICALS & PHARM.  AVON ORGANIC  



Today's Market

Sensex Trades Marginally Higher, Dow Futures Down by 122 Points(12:30 pm)

Share markets in India are presently trading marginally higher. The BSE Sensex is trading up by 91 points, up 0.2%, at 52,744 levels.

Related Views On News

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

More Views on News

Most Popular

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun (Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

OPEC & Our Next Crude Oil Trade (Fast Profits Daily)

Jul 20, 2021

This is why we are on the correct side of the crude oil trade.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUN PHARMA SHARE PRICE


Jul 30, 2021 01:11 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 5-YR ANALYSIS

COMPARE SUN PHARMA WITH

FEATURED VIDEOS

India's Best Drone Stocks

What is the Best Time to Sell a Stock?

What Will Make You Rich Faster: Investing or Trading?

CRISIL v/s CARE Ratings: An Interesting Comparison

More Featured Videos

MARKET STATS